The Role of Maintenance Therapy in AML

Avatar

Oral Azacitidine Prolongs Survival of Patients With AML in Remission Independently of MRD Status

By Barry Skikne 2 Videos
411 views
December 19, 2022
0 Comments
Login to view comments. Click here to Login
11:41
Penn Medicine Abramson Cancer Center

Penn Medicine Updates From Recent Meetings in Hematologic Malignanci…

Feat. C. Lai
15:14
SOHO Brazil 2023

2023 SOHO® Brazil: "Current and Future Approaches to Preventing…

Feat. V. Santini
18:30
SOHO Brazil 2023

2023 SOHO® Brazil: "MDS & AML Classification Updates - Are …

Feat. V. Santini
05:22
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Five-Year Follow-Up Update of Defined-Com…

Feat. E. Liang
26:47
Tisch Cancer Institute at Mount Sinai

2023 Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sin…

Feat. M. Wu
30:34
UChicago Medicine

2023 Updates in AML and MDS

Feat. O. Odenike
12:50
Margaret Kasner

The Importance of Maintenance Therapy in AML: What Oncologists Need …

14:06
SOHO 4th Italian Conference

Maintenance in AML: Trials or Reality?

Feat. M. Gottardi
15:59
SOHO 4th Italian Conference

Non-Intensive Treatment of Older/Unfit Patients With AML

Feat. T. Kadia
09:54
Northwestern Medicine Oncology and Hematology

Maintenance Therapies in Acute Myeloid Leukemia

Feat. Y. Abaza
07:19
PrecisCa

FLT3-Mutated AML: Interpreting Recent Data on Maintenance TKI After …

Feat. Y. Chen
09:42
ASH 2022 Conference Coverage

Transplant in AML With MRD: Proceed or Defer?

Feat. C. Craddock
09:54
Maxim Norkin

QUAZAR AML-001 Trial: Prognostic Impact of NPM1 & FLT3 Mutations…

14:41
ASH 2022 Conference Coverage

Clinical Implications of the QUAZAR AML-001 Trial: Oral AZA Maintena…

Feat. P. Michael
09:52
Massachusetts General Hospital Cancer Center

Maintenance Therapy in AML: Protecting Remission, Extending Survival…

Feat. A. Brunner